Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2009(8): 1355-1369
DOI: 10.1055/s-0028-1088033
DOI: 10.1055/s-0028-1088033
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
Dendrimers of Vaccines Consisting of Tumor-Associated Glycopeptide Antigens and T Cell Epitope Peptides
Further Information
Received
17 October 2008
Publication Date:
25 March 2009 (online)
Publication History
Publication Date:
25 March 2009 (online)

Abstract
According to the principle of multiple antigen presentation (MAP), a di-lysyl lysine core was used for the synthesis of tetramers of a glycododecapeptide antigen from the tandem-repeat sequence of the tumor-associated mucin, MUC1, which carries a sialyl TN-antigen saccharide side chain. The methodology was extended to the analogous construction of a tetrameric vaccine consisting of a T cell epitope from tetanus toxoid and the sialyl TN-glycododecapeptide of MUC1.
Key words
tumor-associated antigens - glycopeptides - fragment condensation - MUC1 - multiple antigen presentation
- For reviews, see:
-
1a
Taylor-Papadimitriou J.Burchell JM.Miles DW.Daziel M. Biochim. Biophys. Acta 1999, 1455: 301 -
1b
Hanisch FG.Ninkovic T. Curr. Protein Pept. Sci. 2006, 7: 307 - 2
Burchell JM.Mungul A.Taylor-Papadimitriou J. J. Mammary Gland Biol. Neoplasia 2001, 6: 355 -
3a For
a review, see:
Liakatos A.Kunz H. Curr. Opin. Mol. Ther. 2007, 9: 35 -
3b
Becker T.Dziadek S.Wittrock S.Kunz H. Curr. Cancer Drug Targets 2006, 6: 491 - 4
Muller S. In Synthetic Peptides as Antigens Vol. 28:Pillai S.van der Vliet PC. Elsevier; Amsterdam: 1999. p.79-31 -
5a
Kunz H.Birnbach S. Angew. Chem. 1986, 98: 354 -
5b
Kagan E.Ragupathi G.Yi SS.Reis CA.Gildersleeve J.Kahne D.Clausen H.Danishefsky SJ.Livingston PO. Cancer Immunol. Immunother. 2005, 54: 424 -
5c
Wittrock S.Becker T.Kunz H. Angew. Chem. Int. Ed. 2007, 46: 5226 ; Angew. Chem. 2007, 119, 5319, and references cited therein -
6a
Buskas T.Ingale S.Boons G.-J. Angew. Chem. Int. Ed. 2005, 44: 5985 ; Angew. Chem. 2005, 117, 6139-6142 -
6b
Dziadek S.Hobel A.Schmitt E.Kunz H. Angew. Chem. Int. Ed. 2005, 44: 7630 ; Angew. Chem. 2005, 117, 7803 - 7
Tam JP. Proc. Natl. Acad. Sci. U.S.A. 1988, 85: 5409 - 8
Keil S.Claus C.Dippold W.Kunz H. Angew. Chem. Int. Ed. 2001, 40: 366 ; Angew. Chem. 2001, 113, 379 -
9a
Rock KL. Immunol. Today 1996, 17: 131 -
9b
Ota S.Ono T.Morita A.Uenaka A.Harada M.Nakayama E. Cancer Res. 2002, 62: 1471 - 10
Roy R. Drug Discovery Today: Technologies 2004, 1: 327 - 11
Seitz O.Kunz H. J. Org. Chem. 1997, 62: 813 - 12
Knorr R.Trceziak A.Bannwarth W.Gillessen D. Tetrahedron Lett. 1989, 30: 1927 - 13
König W.Geiger R. Chem. Ber. 1970, 103: 788 - 14
Carpino L.El-Faham A.Minor CA.Albericio F. J. Chem. Soc., Chem. Commun. 1994, 2001 - 15
Wagner M.Dziadek S.Kunz H. Chem. Eur. J. 2003, 9: 6018 - 16
Kitaguchi H.Hiroshi M.Itoh I.Isamu K.Alexander M. Agric. Biol. Chem. 1991, 55: 3067 - 17
Perrin DD.Armarego WLF. Purification of Laboratory Chemicals 3rd ed.: Pergamon Press; Oxford: 1988. - 18
Belleau B.Malik G. J. Am. Chem. Soc. 1968, 90: 1651